NEU 3.50% $14.05 neuren pharmaceuticals limited

Evans partners report on Neu

  1. 2,369 Posts.
    lightbulb Created with Sketch. 2117
    Evans and Partners have come out with a report on Neuren ,with a current valuation of $5.40 and upside to $7.70 if trofinetide is successful.Only clients of Evans have access to the report .
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.